| Business Summary | | Synbiotics
Corporation
is
a
provider
of
rapid
diagnostic
and
laboratory
diagnostic
products
for
the
animal
healthcare
industry.
The
Company
is
one
of
a
small
number
of
companies
that
focuses
exclusively
on
animal
health.
Synbiotics
also
markets
certain
feline
vaccine
products.
The
Company's
strategy
in
the
animal
health
business
is
to
grow
from
its
established
position
in
the
market
through
new
products
and
technologies,
expanded
distribution,
enhanced
marketing
and
acquisitions
and
licensing. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Synbiotics
Corpoaration
develops,
manufactures,
and
markets
diagnostic
products
and
biological
products
for
animals.
SBIO
also
develops
and
manufactures
specialty
products
which
are
marketed
to
veterinerians.
For
the
three
months
ended
3/31/01,
sales
decreased
13%
to
$8
million.
Net
income
applicable
to
Common
totalled
$795
thousand,
vs.
a
loss
of
$866
thousand.
Results
reflect
lower
vaccine
and
instrument
product
sales,
offset
by
the
disposition
of
W3COMMERCE. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Rigdon Currie, 70 Chairman | -- | Paul Rosinack, 54 Pres,
CEO, Director | $231K | Michael Green, 45 CFO,
Sr. VP, Sec. | 179K | Robert Buchanan, 54 VP
of Sales and Marketing | -- | Francois Guillemin, 51 VP | 136K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|